文献速递眼底病与葡萄膜炎

抗血管内皮生长因子治疗可改善糖尿病视网膜病变评分而视网膜灌注无变化

ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION.
PubMed 文献 · Retina · 2019-01-01

该回顾性干预队列研究分析14例糖尿病视网膜病变患者18只眼,在每月一次连续三次抗血管内皮生长因子注射后,比较超广角荧光素血管造影的视网膜灌注变化与超广角彩色眼底照相的病变变化。结果显示61%眼糖尿病视网膜病变严重程度评分至少改善一个分期,红点数量显著减少,但非灌注区无小动脉或小静脉再灌注。

要点

  • 连续三次抗血管内皮生长因子注射后,61%眼糖尿病视网膜病变严重程度评分至少改善一个分期。
  • 红点平均数量从基线139±130显著减少至第三次注射后1个月80±85(P<0.0001)。
  • 非灌注区及其周围未见小动脉或小静脉再灌注。

核心结论

  • 抗血管内皮生长因子注射后,基于彩色眼底照相的糖尿病视网膜病变严重程度评分改善可发生在超广角荧光素血管造影视网膜灌注无变化的情况下。

研究设计与样本

  • 回顾性干预队列研究,分析14例糖尿病视网膜病变患者共18只眼的资料。
  • 在基线(M0)和第三次抗血管内皮生长因子注射后1个月(M3)分析超广角彩色眼底照相和荧光素血管造影。

主要发现

  • 糖尿病视网膜病变严重程度评分在11/18(61%)眼中至少改善一个分期。
  • 红点平均数量在M3为80±85,显著低于M0的139±130(P<0.0001)。
  • 在非灌注区内或周围未观察到小动脉或小静脉再灌注。

关键数值与推荐

  • 主要结局包括红点(微血管瘤、出血)计数、糖尿病视网膜病变严重程度评分评估,以及荧光素血管造影上非灌注区分析和小动脉或小静脉消失或重现。

临床怎么用

  • 解读抗血管内皮生长因子治疗后糖尿病视网膜病变评分改善时,不应假定视网膜灌注已恢复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the changes in retinal perfusion on ultra-wide-field fluorescein angiography with the changes in diabetic retinopathy lesions observed on ultra-wide-field fundus color photographs after 3 monthly anti-vascular endothelial growth factor injections. METHODS: Retrospective interventional cohort study analyzing the files of 14 patients with DR (18 eyes). UWF color photos and FA were analyzed at baseline (M0) and 1 month after the third anti-VEGF injection (M3). The main outcomes included the count of the number of red dots (microaneurysms, hemorrhages) and assessment of DR severity score (DRSS); the analysis of non-perfusion areas and disappearance or reappearance of arterioles or venules in the non-perfusion areas on FA. RESULTS: Eighteen eyes of 14 diabetic patients, with mean age of 63 ± 5 years, were included. The DRSS score improved by at least one stage in 11/18 (61%) eyes. The mean number of red dots significantly decreased at M3 (n = 80 ± 85) compared with M0 (n = 139 ± 130) (P < 0.0001). No reperfusion of arterioles or venules was observed in or around nonperfusion areas. CONCLUSION: After anti-vascular endothelial growth factor injections, the improvement in the DRSS score based on color fundus photographs can occur without retinal reperfusion on ultra-wide-field fluorescein angiography.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Bonnin S, Dupas B, Lavia C, et al. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION. Retina. 2019. PMID: 30664126. doi:10.1097/IAE.0000000000002422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。